Published in Stem Cells on September 28, 2006
Sialic acids in human health and disease. Trends Mol Med (2008) 2.61
Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med (2010) 1.99
The glycans of stem cells. Curr Opin Chem Biol (2007) 1.45
Multiple changes in sialic acid biology during human evolution. Glycoconj J (2008) 1.43
Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk. Xenotransplantation (2011) 1.27
Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products. PLoS One (2009) 1.24
The N-glycome of human embryonic stem cells. BMC Cell Biol (2009) 1.21
Innovation in the culture and derivation of pluripotent human stem cells. Curr Opin Biotechnol (2008) 1.18
Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res (2014) 1.09
Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures. Transfus Med Hemother (2013) 1.08
Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells. Transfus Med Hemother (2008) 1.07
Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J (2008) 1.05
Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Eng Part A (2010) 1.05
Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. Semin Immunopathol (2011) 0.98
Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions. PLoS One (2010) 0.98
Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res (2012) 0.97
A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells. Cytotechnology (2015) 0.91
Application of biomaterials to advance induced pluripotent stem cell research and therapy. EMBO J (2015) 0.90
Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture. J Cell Mol Med (2014) 0.90
Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media. Sci Rep (2015) 0.89
A fully autologous co-culture system utilising non-irradiated autologous fibroblasts to support the expansion of human keratinocytes for clinical use. Cytotechnology (2011) 0.85
Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation. Stem Cell Res Ther (2015) 0.84
Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng (2015) 0.83
Chemically Defined and Xeno-Free Cryopreservation of Human Adipose-Derived Stem Cells. PLoS One (2016) 0.81
cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness. Sci Rep (2016) 0.81
N-glycosylation profile of undifferentiated and adipogenically differentiated human bone marrow mesenchymal stem cells: towards a next generation of stem cell markers. Stem Cells Dev (2013) 0.81
Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture. Stem Cell Res Ther (2012) 0.81
Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells. Int J Biol Sci (2015) 0.81
Osteogenic differentiation of human dental pulp stem cells on β-tricalcium phosphate/poly (l-lactic acid/caprolactone) three-dimensional scaffolds. J Tissue Eng (2012) 0.81
Culture bag systems for clinical applications of adult human neural crest-derived stem cells. Stem Cell Res Ther (2014) 0.80
Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives. Methods Mol Biol (2013) 0.79
Different culture conditions modulate the immunological properties of adipose stem cells. Stem Cells Transl Med (2014) 0.78
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications. Stem Cells Int (2015) 0.77
Xeno-free chondrogenesis of bone marrow mesenchymal stromal cells: towards clinical-grade chondrocyte production. Cytotechnology (2014) 0.76
Osteogenic differentiation of mesenchymal stromal cells in two-dimensional and three-dimensional cultures without animal serum. Stem Cell Res Ther (2015) 0.76
Extracellular o-linked N-acetylglucosamine is enriched in stem cells derived from human umbilical cord blood. Biores Open Access (2014) 0.76
Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke. Stem Cells Int (2016) 0.76
Ex vivo expansion of bovine corneal endothelial cells in xeno-free medium supplemented with platelet releasate. PLoS One (2014) 0.75
Extracellular Matrix-Dependent Generation of Integration- and Xeno-Free iPS Cells Using a Modified mRNA Transfection Method. Stem Cells Int (2016) 0.75
Safety of Cultivated Limbal Epithelial Stem Cell Transplantation for Human Corneal Regeneration. Stem Cells Int (2017) 0.75
Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins. Cell Chem Biol (2016) 0.75
Biomaterials for pluripotent stem cell engineering: From fate determination to vascularization. J Mater Chem B Mater Biol Med (2016) 0.75
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod (2003) 2.66
A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet (2003) 2.02
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 2.01
Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells (2005) 1.86
Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation (2002) 1.83
IL-17 immunity in human type 1 diabetes. J Immunol (2010) 1.67
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. Br J Pharmacol (2006) 1.67
Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J Invest Dermatol (2003) 1.57
Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes (2003) 1.48
Influence of oocytes and spermatozoa on early embryonic development. Fertil Steril (2002) 1.46
Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells (2005) 1.42
A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One (2010) 1.39
Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes (2004) 1.34
Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes (2006) 1.33
Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet (2005) 1.29
Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model. Proc Natl Acad Sci U S A (2013) 1.28
Distinct differentiation characteristics of individual human embryonic stem cell lines. BMC Dev Biol (2006) 1.24
Transcription factor GATA-6 is expressed in the endocrine and GATA-4 in the exocrine pancreas. Mol Cell Endocrinol (2004) 1.23
Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun (2003) 1.22
Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res (2004) 1.21
The N-glycome of human embryonic stem cells. BMC Cell Biol (2009) 1.21
Frozen embryo transfers: implications of clinical and embryological factors on the pregnancy outcome. Hum Reprod (2006) 1.21
Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1. Mol Cell Biol (2002) 1.20
Lipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes. Eur J Biochem (2004) 1.20
ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology (2002) 1.19
Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Hum Gene Ther (2007) 1.19
The mechanism of action of induced membranes in bone repair. J Bone Joint Surg Am (2013) 1.18
Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod (2005) 1.16
Early cleavage predicts the viability of human embryos in elective single embryo transfer procedures. Hum Reprod (2003) 1.12
Isolation of mononuclear cells from human cord blood by Ficoll-Paque density gradient. Curr Protoc Stem Cell Biol (2007) 1.10
The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope. Glycobiology (2010) 1.10
Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. Reproduction (2006) 1.09
Cultures of human embryonic stem cells: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor. Reprod Biomed Online (2004) 1.08
Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines. Stem Cells Transl Med (2013) 1.06
Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J (2008) 1.05
Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol (2007) 1.04
N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells. Exp Hematol (2007) 1.03
Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support. J Cell Mol Med (2008) 1.03
Restricted ethnic diversity in human embryonic stem cell lines. Nat Methods (2010) 1.02
Effect of developmental stage of embryo at freezing on pregnancy outcome of frozen-thawed embryo transfer. Hum Reprod (2003) 1.01
Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. Eur J Immunol (2012) 1.01
Proliferation and plasticity of human beta cells on physiologically occurring laminin isoforms. Mol Cell Endocrinol (2012) 1.00
Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D₃ via the NF-κB pathway. FASEB J (2012) 0.99
In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions. J Clin Invest (2011) 0.99
Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. J Invest Dermatol (2002) 0.98
Weighing up beta-cell mass in mice and humans: self-renewal, progenitors or stem cells? Mol Cell Endocrinol (2008) 0.98
The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells. Exp Cell Res (2012) 0.98
Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res (2009) 0.97
Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. Biochemistry (2006) 0.97
Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY). Diabetes Care (2009) 0.96
Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells. BMC Cell Biol (2006) 0.96
Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol (2005) 0.96